Bloomage BioTechnology Corporation Limited (SHA:688363)
China flag China · Delayed Price · Currency is CNY
43.00
-0.96 (-2.18%)
At close: Mar 20, 2026

SHA:688363 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-719.271,1691,6061,807
Trading Asset Securities
-30.02140.04530.72846.89
Cash & Short-Term Investments
728.48749.291,3092,1372,654
Cash Growth
-2.78%-42.75%-38.75%-19.47%25.58%
Accounts Receivable
-547.38450.19457.87402.22
Other Receivables
-45.2739.4251.9128.9
Receivables
-592.65489.61509.78431.12
Inventory
-1,2481,1351,162709.13
Other Current Assets
-150.96189.99214.93190.37
Total Current Assets
-2,7413,1234,0233,984
Property, Plant & Equipment
-4,2033,6572,9132,305
Long-Term Investments
-585.02502.99592.63400.32
Goodwill
-174.09251.28247.2267.15
Other Intangible Assets
-490.63496.97475.06467.26
Long-Term Deferred Tax Assets
-355.56336.98302.59246.11
Long-Term Deferred Charges
-100.3498.14116.4331.85
Other Long-Term Assets
-7.513.6311.51.44
Total Assets
-8,6578,4708,6827,504
Accounts Payable
-195.41186.78247.75243.55
Accrued Expenses
-587.09479.49672.75704.09
Short-Term Debt
-49.92-139.2-
Current Portion of Long-Term Debt
-28.89106.0836.5436.46
Current Portion of Leases
-62.7947.0553.6749.61
Current Income Taxes Payable
-13.8555.6876.43135.52
Current Unearned Revenue
-63.4855.5867.7450.83
Other Current Liabilities
-339.6290.13349.97180.46
Total Current Liabilities
-1,3411,2211,6441,401
Long-Term Debt
-65.122.32107.97144.18
Long-Term Leases
-152.9752.6652.4269.77
Long-Term Unearned Revenue
-253.24205.73188.68182.71
Long-Term Deferred Tax Liabilities
-4.575.095.664.12
Total Liabilities
-1,8171,4871,9991,801
Common Stock
-481.68481.68481.09480
Additional Paid-In Capital
-3,8533,8413,7533,569
Retained Earnings
-2,7002,7082,4091,674
Treasury Stock
--219.95-105.88--
Comprehensive Income & Other
--4.3219.57-9.1-23.91
Total Common Equity
7,0606,8106,9446,6345,699
Minority Interest
-29.6339.3349.213.45
Shareholders' Equity
7,0906,8406,9836,6835,702
Total Liabilities & Equity
-8,6578,4708,6827,504
Total Debt
232.24359.69208.1389.79300.01
Net Cash (Debt)
496.24389.61,1011,7472,354
Net Cash Growth
27.37%-64.60%-37.00%-25.77%12.67%
Net Cash Per Share
1.040.802.283.624.87
Filing Date Shares Outstanding
452.63478.36480.26481.09480
Total Common Shares Outstanding
478.36478.36480.26481.09480
Working Capital
-1,4001,9022,3792,584
Book Value Per Share
14.7614.2414.4613.7911.87
Tangible Book Value
6,3626,1456,1965,9115,165
Tangible Book Value Per Share
13.3012.8512.9012.2910.76
Buildings
-2,4961,7561,3851,269
Machinery
-1,7941,4101,148812.35
Construction In Progress
-640.981,109830.45516.72
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.